Titlebook: Antibacterial Therapy: Achievements, Problems and Future Perspectives; W.-D. Busse,H. Labischinski,H.-J. Zeiler Conference proceedings 199

只看該作者 · 發(fā)表于 2025-3-27 01:32:04

Die Programmiersprache Modula-2,n, the seriously ill patient, or the drug company. One only need look at the popular press — newspapers, magazines, and even the tabloids — to understand the extent of public interest and concern about the drug resistance problem.

只看該作者 · 發(fā)表于 2025-3-27 05:42:14

只看該作者 · 發(fā)表于 2025-3-27 13:12:03

只看該作者 · 發(fā)表于 2025-3-27 15:25:53

Pharmaceutical Industry at the Crossroads: Perspectives for Antibacterial Research,i) resistant than to be (highly) pathogenic. Another consequence of this deterioration is that the new antibiotics have to be bactericidal; combinations can rarely be used against multiresistant clinical isolates, since most often one of the components is inactive.

只看該作者 · 發(fā)表于 2025-3-27 19:22:36

9樓

只看該作者 · 發(fā)表于 2025-3-28 01:37:59

9樓

只看該作者 · 發(fā)表于 2025-3-28 02:52:58

10樓

只看該作者 · 發(fā)表于 2025-3-28 07:53:32

10樓

只看該作者 · 發(fā)表于 2025-3-28 13:41:19

10樓

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 05:44
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved